Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1

Allogeneic hematopoietic stem cell transplantation (alloHSCT) remains the treatment of choice to consolidate remission in patients with poor-risk acute myeloid leukemia (AML). With increasing alternative donors available, the preferred donor or stem cell source is debated. We set out to study outcom...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Versluis, Jurjen, Labopin, Myriam, Ruggeri, Annalisa, Socie, Gerard, Wu, Depei, Volin, Liisa, Blaise, Didier, Milpied, Noel, Craddock, Charles, Yakoub-Agha, Ibrahim, Maertens, Johan, Ljungman, Per, Huynh, Anne, Michallet, Mauricette, Deconinck, Eric, Chevallier, Patrice, Passweg, Jakob, Ciceri, Fabio, Mohty, Mohamad, Cornelissen, Jan J., Nagler, Arnon
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2017
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5738980/
https://ncbi.nlm.nih.gov/pubmed/29296964
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2016002386
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados